FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021208588> ?p ?o ?g. }

• W2021208588 endingPage "1731" @default.
• W2021208588 startingPage "1723" @default.
• W2021208588 abstract "The aim of the study was to examine the effects of pioglitazone (PIO), a peroxisome proliferator-activated receptor (PPAR)-γ agonist, and fenofibrate (FENO), a PPAR-α agonist, as monotherapy and in combination on glucose and lipid metabolism. Fifteen type 2 diabetic patients received FENO (n = 8) or PIO (n = 7) for 3 months, followed by the addition of the other agent for 3 months in an open-label study. Subjects received a 4 h hyperinsulinaemic–euglycaemic clamp and a hepatic fat content measurement at 0, 3 and 6 months. Following PIO, fasting plasma glucose (FPG) (p < 0.05) and HbA1c (p < 0.01) decreased, while plasma adiponectin (AD) (5.5 ± 0.9 to 13.8 ± 3.5 μg/ml [SEM], p < 0.03) and the rate of insulin-stimulated total-body glucose disposal (R d) (23.8 ± 3.8 to 40.5 ± 4.4 μmol kg−1 min−1, p < 0.005) increased. After FENO, FPG, HbA1c, AD and R d did not change. PIO reduced fasting NEFA (784 ± 53 to 546 ± 43 μmol/l, p < 0.05), triacylglycerol (2.12 ± 0.28 to 1.61 ± 0.22 mmol/l, p < 0.05) and hepatic fat content (20.4 ± 4.8 to 10.2 ± 2.5%, p < 0.02). Following FENO, fasting NEFA and hepatic fat content did not change, while triacylglycerol decreased (2.20 ± 0.14 to 1.59 ± 0.13 mmol/l, p < 0.01). Addition of FENO to PIO had no effect on R d, FPG, HbA1c, NEFA, hepatic fat content or AD, but triacylglycerol decreased (1.61 ± 0.22 to 1.00 ± 0.15 mmol/l, p < 0.05). Addition of PIO to FENO increased R d (24.9 ± 4.4 to 36.1 ± 2.2 μmol kg−1 min−1, p < 0.005) and AD (4.1 ± 0.8 to 13.1 ± 2.5 μg/ml, p < 0.005) and reduced FPG (p < 0.05), HbA1c (p < 0.05), NEFA (p < 0.01), hepatic fat content (18.3 ± 3.1 to 13.5 ± 2.1%, p < 0.03) and triacylglycerol (1.59 ± 0.13 to 0.96 ± 0.9 mmol/l, p < 0.01). Muscle adenosine 5′-monophosphate-activated protein kinase (AMPK) activity did not change following FENO; following the addition of PIO, muscle AMPK activity increased significantly (phosphorylated AMPK:total AMPK ratio 1.2 ± 0.2 to 2.2 ± 0.3, p < 0.01). We conclude that PPAR-α therapy has no effect on NEFA or glucose metabolism and that addition of a PPAR-α agonist to a PPAR-γ agent causes a further decrease in plasma triacylglycerol, but has no effect on NEFA or glucose metabolism." @default.
• W2021208588 created "2016-06-24" @default.
• W2021208588 creator A5026337187 @default.
• W2021208588 creator A5034471398 @default.
• W2021208588 creator A5041361251 @default.
• W2021208588 creator A5067855121 @default.
• W2021208588 creator A5072087217 @default.
• W2021208588 creator A5073917506 @default.
• W2021208588 date "2007-05-23" @default.
• W2021208588 modified "2023-10-02" @default.
• W2021208588 title "Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus" @default.
• W2021208588 cites W1587875569 @default.
• W2021208588 cites W1963884181 @default.
• W2021208588 cites W1965393911 @default.
• W2021208588 cites W1967388011 @default.
• W2021208588 cites W1977188464 @default.
• W2021208588 cites W1981982177 @default.
• W2021208588 cites W1984023733 @default.
• W2021208588 cites W1997757017 @default.
• W2021208588 cites W2001266437 @default.
• W2021208588 cites W2003323316 @default.
• W2021208588 cites W2012524600 @default.
• W2021208588 cites W2021919208 @default.
• W2021208588 cites W2023100622 @default.
• W2021208588 cites W2023597944 @default.
• W2021208588 cites W2030149161 @default.
• W2021208588 cites W2031773477 @default.
• W2021208588 cites W2036939737 @default.
• W2021208588 cites W2037520352 @default.
• W2021208588 cites W2042706232 @default.
• W2021208588 cites W2047591801 @default.
• W2021208588 cites W2054851194 @default.
• W2021208588 cites W2062560800 @default.
• W2021208588 cites W2077000982 @default.
• W2021208588 cites W2078535741 @default.
• W2021208588 cites W2092621119 @default.
• W2021208588 cites W2100514340 @default.
• W2021208588 cites W2102906564 @default.
• W2021208588 cites W2105912552 @default.
• W2021208588 cites W2107068945 @default.
• W2021208588 cites W2108462699 @default.
• W2021208588 cites W2108916652 @default.
• W2021208588 cites W2113868760 @default.
• W2021208588 cites W2121496639 @default.
• W2021208588 cites W2124232607 @default.
• W2021208588 cites W2127934772 @default.
• W2021208588 cites W2130075209 @default.
• W2021208588 cites W2130623360 @default.
• W2021208588 cites W2131037449 @default.
• W2021208588 cites W2132198142 @default.
• W2021208588 cites W2132525699 @default.
• W2021208588 cites W2132681327 @default.
• W2021208588 cites W2135985666 @default.
• W2021208588 cites W2137046761 @default.
• W2021208588 cites W2140038597 @default.
• W2021208588 cites W2141727688 @default.
• W2021208588 cites W2144829836 @default.
• W2021208588 cites W2149426905 @default.
• W2021208588 cites W2149703192 @default.
• W2021208588 cites W2151025367 @default.
• W2021208588 cites W2165796742 @default.
• W2021208588 cites W2198678228 @default.
• W2021208588 cites W2328529137 @default.
• W2021208588 cites W4244218181 @default.
• W2021208588 doi "https://doi.org/10.1007/s00125-007-0698-9" @default.
• W2021208588 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17520238" @default.
• W2021208588 hasPublicationYear "2007" @default.
• W2021208588 type Work @default.
• W2021208588 sameAs 2021208588 @default.
• W2021208588 citedByCount "122" @default.
• W2021208588 countsByYear W20212085882012 @default.
• W2021208588 countsByYear W20212085882013 @default.
• W2021208588 countsByYear W20212085882014 @default.
• W2021208588 countsByYear W20212085882015 @default.
• W2021208588 countsByYear W20212085882016 @default.
• W2021208588 countsByYear W20212085882017 @default.
• W2021208588 countsByYear W20212085882018 @default.
• W2021208588 countsByYear W20212085882019 @default.
• W2021208588 countsByYear W20212085882020 @default.
• W2021208588 countsByYear W20212085882021 @default.
• W2021208588 countsByYear W20212085882022 @default.
• W2021208588 countsByYear W20212085882023 @default.
• W2021208588 crossrefType "journal-article" @default.
• W2021208588 hasAuthorship W2021208588A5026337187 @default.
• W2021208588 hasAuthorship W2021208588A5034471398 @default.
• W2021208588 hasAuthorship W2021208588A5041361251 @default.
• W2021208588 hasAuthorship W2021208588A5067855121 @default.
• W2021208588 hasAuthorship W2021208588A5072087217 @default.
• W2021208588 hasAuthorship W2021208588A5073917506 @default.
• W2021208588 hasBestOaLocation W20212085881 @default.
• W2021208588 hasConcept C126322002 @default.
• W2021208588 hasConcept C134018914 @default.
• W2021208588 hasConcept C170493617 @default.
• W2021208588 hasConcept C17093226 @default.
• W2021208588 hasConcept C185592680 @default.
• W2021208588 hasConcept C187345961 @default.
• W2021208588 hasConcept C2776782570 @default.
• W2021208588 hasConcept C2777180221 @default.

• next